Samyang Holdings Biopharm Group held a webinar at the ‘IMCAS Academy’ to publicize the safety and effectiveness of Croquis and introduce procedures for its use.
IMCAS (International Master Course on Aging Science) is one of the world’s three major aesthetic societies. It is an academic society where skin and plastic surgery authorities from around the world gather to share the latest trends and medical technologies. The IMCAS Academy is an academic society run by the society. It is an online lecture platform. Samyang Holdings Biopharm Group has been participating in the IMCAS Academy since 2020 and presenting on the effectiveness and safety of Croquis for three consecutive years.
Samyang Holdings Biopharm Group held this webinar under the theme of ‘Bio Stimulation & Lifting Effect with PDO THREADS’. ▲Facial anatomy theory for effective and safe treatment ▲Providing the lifting effect of Croquis The overall lifting procedure using croquis was presented together with global medical staff, including clinical cases, croquis treatment methods, and side effect prevention methods. In particular, this year, the side effects that may occur during the procedure, their causes, prevention, and treatment methods were announced and received a positive response from the audience.
Samyang Holdings Biopharm Group hired three Brazilian cosmetic plastic surgeons, Dr. Clara Santos, Dr. Patrica Omiga, and Fabiano, to focus on targeting the Central and South American markets. Dr. Fabiano Leal was featured as a speaker. The three speakers are considered highly influential specialists in the Brazilian cosmetic surgery market based on their experience in various clinical procedures. According to the Korea Trade-Investment Promotion Agency (KOTRA), Central and South America is an emerging growth market with the second highest interest in cosmetic surgery in the world after the United States, showing a growth rate of more than double digits every year. In particular, Brazil is known as the largest market for cosmetic surgery in Latin America, with approximately 1.9 million cosmetic procedures (fillers, botox, thread lifting, etc.) performed annually.
About 1,360 medical staff from around the world pre-registered for Samyang Holdings Biopharm Group’s webinar, and about 435 people simultaneously logged in and watched the lecture in real-time. Among IMCAS’s many webinars in various categories, this is the largest number of participants on the topic of threads for cosmetic surgery alone, and this webinar once again confirmed the high interest of global medical staff in Croquis.
Youngjun Lee, CEO of Samyang Holdings Biopharm Group, said, “This webinar is meaningful in that it secured clinical cases not only in Europe and Japan, but also in Central and South America and proved it internationally,” adding, “We will continue to collaborate with global professional medical staff from various countries.” “We will secure international recognition for Croquis and actively promote overseas exports to expand the market base around the world,” he said.
Samyang Holdings Biopharm Group’s lifting thread brand ‘Croqui’ has announced the results of a global case study targeting overseas markets immediately after its launch, proving its effectiveness and safety in the global market through data. To date, sales contracts have been concluded in 18 countries around the world, including Europe, Japan, and Central and South America, and the marketing approval process is in progress in the United States and Australia. Last June, we participated in ‘IMCAS 2022’ held in France, demonstrating the croquis procedure and presenting research results with global medical staff. We also set up an exhibition booth and conducted consultations with global companies to expand exports.
Meanwhile, Samyang Holdings Biopharm Group is overcoming the disadvantages of latecomers and gaining trust in the global cosmetic surgery industry by implementing data-driven marketing. While existing cosmetic surgery thread brands only emphasize the comparative effects before and after the procedure, Samyang Holdings Biopharm Group is securing various data to prove the correlation between the treatment effect for each facial area and the physical properties of the thread with the goal of evidence-based marketing.
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asian Innovation Hub Pangyo Techno Valley 2022’ news